Medical devices, healthcare technology and the business of care
510(k) clearance · K252873

Q Interbody Instruments

K2m, Inc. · Decision date Feb 6, 2026

FDA DECISIONK252873

What did the FDA decide?

FDA records K252873 as a 510(k) premarket notification, with a decision dated Feb 6, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Feb 6, 2026

FDA source record

Regulatory record facts

Identifier
K252873
Regulatory pathway
510(k) premarket notification
Applicant
K2m, Inc.
Product code
OLO
Decision code
SESE
Decision date
Feb 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthopedic Stereotaxic Instrument.

Applicant
K2m, Inc.
Product code
OLO
FDA device class
2

FDA decision timeline

  1. K252873 received

    Application receipt date recorded by FDA.

  2. K252873 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OLO

Product / regulatory recordCompanyPathwayDecision dateSource
GPS AnkleK262567
Blue Ortho510(k) clearanceOct 26, 2026FDA
7D Surgical ULC510(k) clearanceOct 19, 2026FDA
THINK Surgical, Inc.510(k) clearanceOct 16, 2026FDA
CarboFix Orhtopedics , Ltd.510(k) clearanceOct 9, 2026FDA
Brainlab SE510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

K2m, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Leesburg, VA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records